Rationale and Design of the ‘MITOCARE’ Study: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of TRO40303 for the Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction
Author:
- MITOCARE Study GroupMGMITOCARE Study Group
Open Access
- 15 November 2012
- journal article
- research article
- Published by S. Karger AG in Cardiology
- Vol. 123 (4) , 201-207
Abstract
Treatment of acute ST-elevation myocardial infarction (STEMI) by reperfusion using percutaneous coronary intervention (PCI) or thrombolysis has provided clinical benefits; however, it also induces considerable cell death. This process is called reperfusion injury. The continuing high rates of mortality and heart failure after acute myocardial infarction (AMI) emphasize the need for improved strategies to limit reperfusion injury and improve clinical outcomes. The objective of this study is to assess safety and efficacy of TRO40303 in limiting reperfusion injury in patients treated for STEMI. TRO40303 targets the mitochondrial permeability transition pore, a promising target for the prevention of reperfusion injury. This multicenter, double-blind study will randomize patients with STEMI to TRO40303 or placebo administered just before balloon inflation or thromboaspiration during PCI. The primary outcome measure will be reduction in infarct size (assessed as plasma creatine kinase and troponin I area under the curve over 3 days). The main secondary endpoint will be infarct size normalized to the myocardium at risk (expressed by the myocardial salvage index assessed by cardiac magnetic resonance). The study is being financed under an EU-FP7 grant and conducted under the auspices of the MITOCARE research consortium, which includes experts from clinical and basic research centers, as well as commercial enterprises, throughout Europe. Results from this study will contribute to a better understanding of the complex pathophysiology underlying myocardial injury after STEMI. The present paper describes the rationale, design and the methods of the trial.Keywords
This publication has 26 references indexed in Scilit:
- Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary interventionEuropean Heart Journal, 2011
- Assessment of myocardium at risk with contrast enhanced steady-state free precession cine cardiovascular magnetic resonance compared to single-photon emission computed tomographyJournal of Cardiovascular Magnetic Resonance, 2010
- Cardioprotective Effects of Ischemic Postconditioning in Patients Treated With Primary Percutaneous Coronary Intervention, Evaluated by Magnetic ResonanceCirculation: Cardiovascular Interventions, 2010
- Role of cardiac magnetic resonance imaging in ischaemic heart diseaseInternal Medicine Journal, 2009
- Myocardium at Risk After Acute Infarction in Humans on Cardiac Magnetic ResonanceJACC: Cardiovascular Imaging, 2009
- The mitochondrial permeability transition pore and ischemia-reperfusion injuryBasic Research in Cardiology, 2009
- Infarct evolution in man studied in patients with first-time coronary occlusion in comparison to different species - implications for assessment of myocardial salvageJournal of Cardiovascular Magnetic Resonance, 2009
- Rapid Initial Reduction of Hyperenhanced Myocardium After Reperfused First Myocardial Infarction Suggests Recovery of the Peri-Infarction ZoneCirculation: Cardiovascular Imaging, 2009
- Myocardial Reperfusion InjuryNew England Journal of Medicine, 2007
- Postconditioning the Human HeartCirculation, 2005